Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02460692 · ClinicalTrials.gov registry record · Phase 2
Trial of Dronabinol and Vaporized Cannabis in Chronic Low Back Pain
A Phase 2 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 2
- Development phase
- 131
- Enrollment target
NCT02460692 is a Phase 2 study that has completed, run by University of California, San Diego. The registered enrollment target is 131 participants.
The verdict
NCT02460692, a Phase 2 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 131 participants
- Enrollment target
Study Summary
This study will involve treating low back pain associated with nerve injury with oral delta-9-tetrahydrocannabinol (Δ9-THC) or whole plant cannabis for eight weeks. Research subjects will consume either oral Δ9-THC (dronabinol), vaporized 3.7% Δ9-THC/5.6% CBD, or placebo. An analysis will then be determined to assess the risk--benefit ratio of dronabinol and vaporized 3.7% Δ9-THC/5.6% CBD .
Interventions
- DRUG Placebos
- DRUG dronabinol
- DRUG Vaporized Cannabis 3.7% THC/5.6% CBD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2016-12 |
| Est. Completion | 2020-03-25 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02460692
The ClinicalTrials.gov registry entry for NCT02460692 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 131 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebos is the first listed.
NCT02460692 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02460692 about?
NCT02460692 is a clinical study titled "Trial of Dronabinol and Vaporized Cannabis in Chronic Low Back Pain". This study will involve treating low back pain associated with nerve injury with oral delta-9-tetrahydrocannabinol (Δ9-THC) or whole plant cannabis for eight weeks. Research subjects will consume either oral Δ9-THC (dronabinol), vaporized 3.7% Δ9-THC/5.6% CBD, or placebo. An analysis will then be de...
What is the current status of trial NCT02460692?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 131 participants. The study started on 2016-12. Estimated completion is 2020-03-25.
What interventions are being tested in trial NCT02460692?
The interventions under investigation include: Placebos (DRUG), dronabinol (DRUG), Vaporized Cannabis 3.7% THC/5.6% CBD (DRUG).
Who is sponsoring clinical trial NCT02460692?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.